Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Apr 01, 2024

SELL
$67.18 - $84.11 $493,974 - $618,460
-7,353 Closed
0 $0
Q2 2022

Apr 01, 2024

BUY
$66.18 - $83.18 $486,621 - $611,622
7,353 New
7,353 $759 Million
Q3 2021

Apr 01, 2024

SELL
$68.67 - $84.02 $1.07 Million - $1.31 Million
-15,638 Closed
0 $0
Q2 2021

Apr 01, 2024

BUY
$79.87 - $87.53 $32,586 - $35,712
408 Added 2.68%
15,638 $1.32 Billion
Q1 2021

Apr 01, 2024

BUY
$76.02 - $100.5 $885,404 - $1.17 Million
11,647 Added 325.06%
15,230 $1.24 Billion
Q4 2020

Apr 01, 2024

SELL
$80.74 - $97.7 $289,129 - $349,863
-3,581 Reduced 49.99%
3,583 $312 Million
Q3 2020

Apr 01, 2024

SELL
$85.07 - $109.69 $170 - $219
-2 Reduced 0.03%
7,164 $643 Million
Q2 2020

Apr 01, 2024

SELL
$74.18 - $108.93 $222 - $326
-3 Reduced 0.04%
7,166 $745 Million
Q1 2020

Apr 01, 2024

SELL
$63.18 - $85.97 $452,747 - $616,061
-7,166 Reduced 49.99%
7,169 $525 Million
Q3 2019

Apr 01, 2024

BUY
$72.82 - $86.52 $522,337 - $620,607
7,173 Added 100.15%
14,335 $1.28 Billion
Q1 2019

Apr 01, 2024

BUY
$63.56 - $88.17 $156,230 - $216,721
2,458 Added 52.25%
7,162 $616 Million
Q4 2018

Apr 01, 2024

BUY
$58.5 - $69.94 $275,184 - $328,997
4,704 New
4,704 $299 Million
Q4 2017

Apr 03, 2024

SELL
$93.56 - $116.6 $228,660 - $284,970
-2,444 Closed
0 $0
Q2 2017

Apr 03, 2024

SELL
N/A
-6,815 Reduced 73.6%
2,444 $308 Million
Q2 2016

Apr 03, 2024

BUY
N/A
2 Added 0.02%
9,259 $741 Million
Q1 2016

Apr 03, 2024

BUY
N/A
3,789 Added 69.29%
9,257 $671 Million
Q4 2015

Apr 03, 2024

BUY
N/A
5,468 New
5,468 $593 Million
Q2 2014

Apr 03, 2024

SELL
N/A
-9,231 Closed
0 $0
Q4 2013

Apr 03, 2024

SELL
N/A
-6,937 Reduced 42.91%
9,231 $467 Million
Q2 2013

Apr 03, 2024

SELL
N/A
-3,541 Reduced 17.97%
16,168 $356 Million
Q1 2013

Apr 03, 2024

BUY
N/A
19,709 New
19,709 $461 Million
Q4 2012

Apr 08, 2024

BUY
N/A
19,887
19,887 $330 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.